Oncotarget.net features press releases on the latest oncology research, as well as interviews from the distinguished network of authors who continue to publish their research with Oncotarget.

Tag: Rapamycin

Figure 2: Rapamycin prevents cancer by slowing tumor progression (hypothetical schema).

Oncotarget

Cancer Prevention With Rapamycin

April 17, 2023

“[...] long-term treatment with rapamycin slows down aging, a major risk factor for cancer [...]” Listen to an audio version of this press release BUFFALO, NY- April 17, 2023 –… read more

Oncotarget

Behind the Study: Metformin and Rapamycin as Maintenance Therapy

December 13, 2021

Dr. Katherine Bever from Johns Hopkins University discusses a research paper she co-authored that was published by Oncotarget, “An exploratory study of metformin with or without rapamycin as maintenance therapy after… read more